Skip to main content
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals.
Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
Interventions for preventing late postnatal mother-to-child transmission of HIV.
Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.
Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.